4 February 2022 - The field of cost effectiveness analysis has grown rapidly but in somewhat lopsided fashion.
The number of published cost per quality-adjusted life year analyses increased from an average of 34 per year from 1990 to 1999, to 484 per year from 2010 to 2014, to 856 per year from 2016 to 2020.
However, the analyses have disproportionately focused on prescription drugs, with relatively less attention to health services and procedures.